GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Teladoc Health Inc (NYSE:TDOC) » Definitions » Net Issuance of Preferred Stock

TDOC (Teladoc Health) Net Issuance of Preferred Stock : $0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Teladoc Health Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Teladoc Health's net issuance of preferred for the three months ended in Mar. 2025 was $0 Mil. The number is 0, which means that Teladoc Health has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Teladoc Health's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2025 was $0 Mil.


Teladoc Health Net Issuance of Preferred Stock Historical Data

The historical data trend for Teladoc Health's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teladoc Health Net Issuance of Preferred Stock Chart

Teladoc Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Issuance of Preferred Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Teladoc Health Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Teladoc Health Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Teladoc Health Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Teladoc Health's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Teladoc Health Business Description

Address
2 Manhattanville Road, Suite 203, Purchase, NY, USA, 10577
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with Better convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
Executives
Mala Murthy officer: Chief Financial Officer C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Adam C Vandervoort officer: Chief Legal Officer, Secretary 485 MADISON AVENUE, NEW YORK NY 10022
Thomas Mckinley director
Andrew Turitz officer: SVP - Business Development C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Vidya Raman-tangella officer: Chief Medical Officer 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Michael Willem Waters officer: CHIEF OPERATING OFFICER 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Stephany Verstraete officer: Chief Marketing Officer C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Arnnon Geshuri officer: Chief Human Resources Officer 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Daniel Trencher officer: SVP Corporate Strategy 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Mark Douglas Smith director C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Laizer Kornwasser officer: PRESIDENT, ENTERPRISE GROWTH 100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417
Karen L Daniel director 2801 80TH STREET, KENOSHA WI 53141
Jason N Gorevic director, officer: President & CEO
Richard J Napolitano officer: Chief Accounting Officer MSCI INC., 7 WORLD TRADE CENTER, 250 GREENWICH STREET, 49TH FLOOR, NEW YORK NY 10007
Jason Eric Evans director 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027